Ken Kato

83PUBLICATIONS

243CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPredictive and prognostic markersSocial epidemiologyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (83)

Sort by Publication Date:

|Jul 13, 2026

Squamous cell carcinoma antigen and carcinoembryonic antigen monitoring during post-definitive chemoradiotherapy surveillance for esophageal squamous cell carcinoma: JCOG2106A.

|Jun 09, 2026

FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma.

|May 20, 2026

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer.

|Apr 28, 2026

First-line pembrolizumab plus chemotherapy versus chemotherapy alone for advanced esophageal cancer: 5-year extended follow-up in the Japanese subgroup of KEYNOTE-590.

|Mar 31, 2026

First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in adults with advanced or metastatic esophageal squamous cell carcinoma: a Japanese subgroup analysis of RATIONALE-306 with ≥ 3 years of follow-up.

Takashi Ogata, Takashi Kojima, Ryu Ishihara

|Mar 17, 2026

Clinical role of anti-PD-1 immunotherapies in esophageal cancer.

Momoko Sano, Hiroshi Imazeki, Shun Yamamoto

Pageof 14

Frequent Collaborators

12 joint publications

Takayuki Yoshino

10 joint publications

Hideaki Bando

Eiji Oki

Yoshito Komatsu

Hiroki Hara

Hidekazu Hirano

Yoshiaki Nakamura

Juntaro Matsuzaki

Shun Yamamoto

Yu Sunakawa

Frequent Collaborators

12 joint publications

Takayuki Yoshino

10 joint publications

Hideaki Bando

7 joint publications

Eiji Oki

7 joint publications

Yoshito Komatsu